[go: up one dir, main page]

AR108812A1 - Proceso para preparar un derivado de piridona policíclica sustituida y cristal del mismo - Google Patents

Proceso para preparar un derivado de piridona policíclica sustituida y cristal del mismo

Info

Publication number
AR108812A1
AR108812A1 ARP170101679A ARP170101679A AR108812A1 AR 108812 A1 AR108812 A1 AR 108812A1 AR P170101679 A ARP170101679 A AR P170101679A AR P170101679 A ARP170101679 A AR P170101679A AR 108812 A1 AR108812 A1 AR 108812A1
Authority
AR
Argentina
Prior art keywords
formula
compound
crystal
substituted
polychyclic
Prior art date
Application number
ARP170101679A
Other languages
English (en)
Inventor
Toshikatsu Maki
Nobuaki Fukui
Setsuya Shibahara
Kosuke Anan
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60783429&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR108812(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of AR108812A1 publication Critical patent/AR108812A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B61/00—Other general methods
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente solicitud proporciona un proceso para preparar un compuesto de la fórmula (2), donde R² es alquilo no sustituido, caracterizado porque la reacción de un compuesto de la fórmula (1), donde R¹ es hidrógeno o un grupo protector diferente de alquilo no sustituido, con un compuesto de la fórmula: R²-OH, donde R² es como se definió anteriormente, en presencia de una sal de sodio y/o una sal de magnesio, y compuestos. Reivindicación 6: Un proceso para preparar un compuesto de la fórmula (4), donde R³, R⁴, R⁵ y R⁶ son cada uno de modo independiente hidrógeno o halógeno, con la condición de que uno o dos de R³, R⁴, R⁵ y R⁶ es halógeno; caracterizado porque la reacción de un compuesto de la fórmula (2’), con un compuesto de la fórmula (3), donde R³, R⁴, R⁵ y R⁶ son como se definieron anteriormente. Reivindicación 8: Un proceso para preparar el compuesto de la fórmula (5) o fórmula (6), caracterizado porque comprende el proceso de acuerdo con cualquiera de las reivindicaciones 1 a 7. Reivindicación 9: Un compuesto de la fórmula (2’) o una sal de este. Reivindicación 12: Un compuesto de la fórmula (4’) o una sal de este. Reivindicación 15: Un cristal del compuesto de la fórmula (5), o un cristal de una sal farmacéuticamente aceptable de este.
ARP170101679A 2016-06-20 2017-06-19 Proceso para preparar un derivado de piridona policíclica sustituida y cristal del mismo AR108812A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016121453 2016-06-20

Publications (1)

Publication Number Publication Date
AR108812A1 true AR108812A1 (es) 2018-09-26

Family

ID=60783429

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170101679A AR108812A1 (es) 2016-06-20 2017-06-19 Proceso para preparar un derivado de piridona policíclica sustituida y cristal del mismo

Country Status (15)

Country Link
US (2) US11261198B2 (es)
EP (2) EP4194459A1 (es)
JP (2) JP6212678B1 (es)
KR (2) KR102586854B1 (es)
CN (2) CN109311911B (es)
AR (1) AR108812A1 (es)
AU (1) AU2017282305B2 (es)
BR (1) BR112018076600A2 (es)
CA (1) CA3027840A1 (es)
HR (1) HRP20221540T1 (es)
IL (1) IL263812B2 (es)
MX (1) MX2018016267A (es)
SG (1) SG11201810655QA (es)
TW (1) TWI750188B (es)
WO (1) WO2017221869A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102084109B1 (ko) 2015-12-15 2020-03-03 시오노기세야쿠 가부시키가이샤 캡 의존적 엔도뉴클레아제 저해제 및 항인플루엔자 약을 조합하는 것을 특징으로 하는 인플루엔자 치료용 의약
CN109311911B (zh) * 2016-06-20 2021-11-16 盐野义制药株式会社 用于制备取代多环吡啶酮衍生物及其晶体的方法
MA45939A (fr) 2016-08-10 2019-06-19 Shionogi & Co Dérivé de pyridone polycyclique substitué et composition pharmaceutique contenant un promédicament de celui-ci
TWI785116B (zh) 2017-09-18 2022-12-01 大陸商廣東東陽光藥業有限公司 流感病毒複製抑制劑及其用途
CN111386276B (zh) 2017-10-06 2023-06-23 盐野义制药株式会社 制备取代的多环吡啶酮衍生物的立体选择性方法
CN110357850A (zh) * 2018-03-26 2019-10-22 广东东阳光药业有限公司 一种含硫杂环化合物的制备方法
CA3098006A1 (en) 2018-04-24 2019-10-31 Shionogi & Co., Ltd. Solid dosage form having excellent stability
CN108558907B (zh) * 2018-06-01 2019-08-09 海化生命(厦门)科技有限公司 一种关键中间体2的制备方法
CN110872247A (zh) * 2018-08-29 2020-03-10 上海复星星泰医药科技有限公司 Xofluza含硫杂环化合物、其中间体及制备方法
CN109134428A (zh) * 2018-10-25 2019-01-04 南京科技职业学院 一种巴洛沙韦中间体的制备方法
CN111170875B (zh) * 2018-11-09 2022-12-27 广东东阳光药业有限公司 一种二烷氧基胺类化合物的制备方法
CN109721585B (zh) * 2018-12-19 2020-09-29 浙江工业大学 一种巴洛沙韦关键中间体的制备方法
CN109516998B (zh) * 2018-12-25 2021-06-25 深圳市华先医药科技有限公司 一种巴洛沙韦中间体的合成方法
CN109504721B (zh) * 2018-12-26 2021-07-09 杭州科巢生物科技有限公司 一种抗流感药物的合成方法
CN111484508B (zh) * 2019-01-29 2022-11-25 北京四环制药有限公司 一种用于制备巴罗萨韦或其衍生物的化合物及其制备方法和其应用
CN111574386B (zh) * 2019-02-19 2024-02-23 广东东阳光药业股份有限公司 一种氧代乙胺化合物的纯化方法
WO2020181025A1 (en) 2019-03-05 2020-09-10 Assia Chemical Industries Ltd Solid state forms of baloxavir marboxil
SG11202109050WA (en) 2019-03-12 2021-09-29 Shionogi & Co Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof in a subject having influenza and a complication risk factor
CN111825699B (zh) * 2019-04-15 2023-02-21 上海复星星泰医药科技有限公司 含硫杂环化合物及其制备方法
CN110143941B (zh) * 2019-06-04 2021-05-25 北京四环制药有限公司 一种巴罗萨韦玛波酯中间体的合成方法
CN110105327A (zh) * 2019-06-05 2019-08-09 南京焕然生物科技有限公司 一种7,8-二氟-6,11-二氢-二苯并噻吩并-11-醇的制备方法
CN110305091B (zh) * 2019-06-19 2021-05-18 江苏理工学院 一种巴洛沙韦中间体化合物的制备方法
CN112521386B (zh) * 2019-09-19 2023-05-26 周雨恬 具有抗病毒作用的多环吡啶酮化合物及其药物组合和用途
CN114258395A (zh) * 2019-09-27 2022-03-29 广东东阳光药业有限公司 一种酯化合物的晶型及其制备方法
CN112707862B (zh) * 2019-10-24 2022-09-27 广东东阳光药业有限公司 一种并环吡啶酮化合物的制备方法
CN111057070A (zh) * 2019-10-30 2020-04-24 浙江工业大学 一种巴洛沙韦关键中间体的合成方法
WO2021093860A1 (zh) * 2019-11-13 2021-05-20 南京知和医药科技有限公司 取代的双三环化合物及其药物组合物和用途
CN118480041A (zh) * 2019-12-23 2024-08-13 石家庄迪斯凯威医药科技有限公司 取代的多环化合物及其药物组合物和用途
CN111875619B (zh) * 2020-07-30 2021-06-25 深圳市新阳唯康科技有限公司 巴洛沙韦酯的晶型及其制备方法
WO2022128934A1 (en) 2020-12-15 2022-06-23 Synthon B.V. Solid forms of baloxavir, salts of baloxavir and cocrystals of baloxavir
CN114671889A (zh) * 2020-12-24 2022-06-28 江苏威凯尔医药科技有限公司 一种取代三环吡啶酮衍生物的晶型及其制备方法
CN115594692A (zh) * 2021-07-08 2023-01-13 重庆博腾制药科技股份有限公司（Cn） 一种制备抗流感病毒药物中间体的方法
WO2023286078A1 (en) * 2021-07-13 2023-01-19 Natco Pharma Limited An improved process for the preparation of an intermediate of baloxavir morboxil
CN113717199B (zh) * 2021-08-13 2022-04-01 北京北朋科技有限公司 巴洛沙韦的氘代衍生物及其在抗流感病毒中的应用
CN113717200B (zh) * 2021-09-13 2022-11-22 石药集团中奇制药技术（石家庄）有限公司 一种巴洛沙韦中间体的制备方法
CN114014874B (zh) * 2021-12-20 2023-04-28 中国科学院上海药物研究所 一种玛巴洛沙韦中间体的制备方法
CN116082361B (zh) * 2023-04-11 2023-06-13 和鼎（南京）医药技术有限公司 一种制备玛巴洛沙韦中间体和玛巴洛沙韦的方法

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69312306T2 (de) 1992-10-02 1997-11-13 Dow Chemical Co Aufträger homogener komplexkatalysator für olefinpolymerisation
KR100445310B1 (ko) 1996-01-22 2004-10-15 다우 글로벌 테크놀로지스 인크. 향상된성질을나타내는폴리올레핀탄성중합체혼합물
DE19824449A1 (de) 1998-05-30 1999-12-02 Clariant Gmbh Verfahren zur Cyclisierung von Penta- und Hexapeptiden
CN1253958A (zh) 1998-11-18 2000-05-24 华东理工大学 环烯烃开环易位聚合催化剂
CN1324886A (zh) 2000-05-24 2001-12-05 中国科学院化学研究所 一种蒙脱土纳米复合聚烯烃材料及其制备方法
EP1360212A4 (en) 2000-12-29 2004-09-15 Samsung General Chemicals Co METHOD FOR PRODUCING ETHYLENE HOMOPOLYMER AND COPOLYMER
DE10342150A1 (de) 2003-09-12 2005-04-28 Degussa Verfahren zur Oxidation organischer Substrate und Katalysatorzusammensetzung zur Durchführung des Verfahrens
EP1905755A1 (en) 2006-09-26 2008-04-02 Lonza Ag Process for the synthesis of 2,2 ,6-tribromobiphenyl
TW200911873A (en) 2007-05-15 2009-03-16 Plextronics Inc Mixed halogen polymerization
KR100953948B1 (ko) 2007-12-24 2010-04-21 호남석유화학 주식회사 올레핀 중합 촉매의 제조 방법 및 이로부터 제조된 올레핀중합 촉매
US8609574B2 (en) 2008-04-25 2013-12-17 Promerus Llc In situ olefin polymerization catalyst system
CN101462922A (zh) 2009-01-07 2009-06-24 华东理工大学 1,5-环辛二烯的异构化方法
TWI518084B (zh) 2009-03-26 2016-01-21 鹽野義製藥股份有限公司 哌喃酮與吡啶酮衍生物之製造方法
JP5737691B2 (ja) 2009-06-15 2015-06-17 塩野義製薬株式会社 置換された多環性カルバモイルピリドン誘導体
WO2012007758A2 (en) 2010-07-15 2012-01-19 Astrazeneca Ab Pharmaceutical formulations
KR101773226B1 (ko) 2010-09-24 2017-09-12 시오노기세야쿠 가부시키가이샤 치환된 다환성 카르바모일 피리돈 유도체의 프로드러그
JP2012077106A (ja) 2010-09-30 2012-04-19 Daito Chemix Corp 新規なチオフェンポリマー及びその製造方法
CA2826973C (en) 2011-02-10 2020-03-24 Mannkind, Corp Formation of n-protected bis-3,6-(4-aminoalkyl)-2,5,diketopiperazine
EA026681B1 (ru) 2011-03-01 2017-05-31 Эксонмобил Апстрим Рисерч Компани Устройство и системы, имеющие заключенный в оболочку адсорбентный контактор, и связанные с этим циклические адсорбционные процессы
EP2705029B1 (en) * 2011-05-04 2018-10-24 Rhizen Pharmaceuticals S.A. Novel compounds as modulators of protein kinases
WO2012165194A1 (ja) 2011-05-27 2012-12-06 綜研化学株式会社 環状共役系ポリマーの製造方法および環状共役系ポリマー重合用触媒
CN102796208B (zh) 2011-05-27 2014-08-06 中国石油化工股份有限公司 用于烯烃聚合的催化剂组分及其制备方法和用于烯烃聚合的催化剂以及烯烃聚合方法
US20130090439A1 (en) 2011-10-05 2013-04-11 Honeywell International Inc. Polymerization Of 2,3,3,3-Tetrafluoropropene And Polymers Formed From 2,3,3,3-Tetrafluoropropene
EP2774928B1 (en) * 2011-10-12 2017-08-30 Shionogi & Co., Ltd. Polycyclic pyridone derivative having integrase-inhibiting activity
CN103012750B (zh) 2012-11-16 2015-02-04 合肥工业大学 一种两亲性共轭二嵌段共聚物及其制备方法
CN104098481B (zh) 2013-04-10 2016-05-11 浙江九洲药物科技有限公司 一种沙格列汀中间体的制备方法
CN103351443B (zh) 2013-07-16 2016-02-10 华东理工大学 一种负载型烯烃聚合催化剂及其制备方法与应用
CN104292407B (zh) 2013-07-17 2017-05-10 常州锐博生物科技有限公司 一锅法制备聚吡咯与亲水性聚苯异腈二嵌段聚合物
KR101554562B1 (ko) 2013-09-26 2015-09-21 경상대학교산학협력단 마크로스펠라이드 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암 질환의 예방 또는 치료용 약학적 조성물
CN104610479B (zh) 2013-11-05 2017-03-29 中国石油化工股份有限公司 用于乙烯聚合的负载化茂金属催化剂及其制备方法和应用
WO2015124272A1 (de) 2014-02-20 2015-08-27 Innovationlab Gmbh Konjugierte polymere
CN103965450A (zh) 2014-05-13 2014-08-06 合肥工业大学 镍配体催化剂及其制备方法与应用
KR101709199B1 (ko) 2014-10-06 2017-02-23 주식회사 포스코 싸이오펜 중합체 조성물, 및 이를 포함하는 유기광전자소자
EP3018150B1 (en) 2014-11-07 2020-03-11 Indian Oil Corporation Limited Process for the preparation of spherical catalyst particles
EP3230269A1 (en) 2014-11-20 2017-10-18 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Production of furans
WO2016106628A1 (en) 2014-12-31 2016-07-07 Merck Sharp & Dohme Corp. Btk inhibitors
JP2016166287A (ja) 2015-03-09 2016-09-15 国立大学法人東京工業大学 有機半導体用π共役高分子並びにその製造方法及び用途
JP2016169258A (ja) 2015-03-11 2016-09-23 ダイトーケミックス株式会社 ポリチオフェン化合物の製造方法
KR101981880B1 (ko) * 2015-04-28 2019-05-23 시오노기세야쿠 가부시키가이샤 치환된 다환성 피리돈 유도체 및 그의 프로드러그
JP5971830B1 (ja) * 2015-04-28 2016-08-17 塩野義製薬株式会社 置換された多環性ピリドン誘導体およびそのプロドラッグ
CN105131257A (zh) 2015-08-10 2015-12-09 安徽国星生物化学有限公司 一种高等规度聚吡啶及其制备方法
CN106519084B (zh) 2015-09-15 2019-02-15 中国石油天然气股份有限公司 烯烃聚合催化剂用主催化剂及其制备方法与烯烃聚合催化剂
CA3005744A1 (en) 2015-11-17 2017-05-26 Dow Agrosciences Llc 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-oxoethyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
AR106731A1 (es) 2015-11-17 2018-02-14 Viamet Pharmaceuticals Inc 4-((6-(2-(2,4-difluorofenil)-1,1-difluoro-2-hidroxi-3-(1h-1,2,4-triazol-1-il)propil)piridin-3-il)oxi)benzonitrilo y proceso para su preparación
KR102084109B1 (ko) 2015-12-15 2020-03-03 시오노기세야쿠 가부시키가이샤 캡 의존적 엔도뉴클레아제 저해제 및 항인플루엔자 약을 조합하는 것을 특징으로 하는 인플루엔자 치료용 의약
CN105820317B (zh) 2016-05-06 2018-05-15 合肥工业大学 一种序列可控的三嵌段共聚物的制备方法
CN109311911B (zh) * 2016-06-20 2021-11-16 盐野义制药株式会社 用于制备取代多环吡啶酮衍生物及其晶体的方法
MA45939A (fr) 2016-08-10 2019-06-19 Shionogi & Co Dérivé de pyridone polycyclique substitué et composition pharmaceutique contenant un promédicament de celui-ci
US9862675B1 (en) 2017-07-05 2018-01-09 King Fahd University Of Petroleum And Minerals Method of N-formylating amines with a phosphonic anhydride
CN111386276B (zh) 2017-10-06 2023-06-23 盐野义制药株式会社 制备取代的多环吡啶酮衍生物的立体选择性方法

Also Published As

Publication number Publication date
EP3473629B1 (en) 2022-11-16
JP2018024682A (ja) 2018-02-15
SG11201810655QA (en) 2019-01-30
WO2017221869A1 (ja) 2017-12-28
CN113717198A (zh) 2021-11-30
IL263812B2 (en) 2023-09-01
CN109311911B (zh) 2021-11-16
KR102586854B1 (ko) 2023-10-11
TWI750188B (zh) 2021-12-21
US11807648B2 (en) 2023-11-07
IL263812B1 (en) 2023-05-01
EP4194459A1 (en) 2023-06-14
CA3027840A1 (en) 2017-12-28
HRP20221540T1 (hr) 2023-03-03
BR112018076600A2 (pt) 2019-04-16
IL263812A (en) 2019-01-31
CN109311911A (zh) 2019-02-05
KR20220084425A (ko) 2022-06-21
TW201802097A (zh) 2018-01-16
US11261198B2 (en) 2022-03-01
AU2017282305B2 (en) 2021-06-10
US20220251107A1 (en) 2022-08-11
KR102447711B1 (ko) 2022-09-28
AU2017282305A1 (en) 2018-12-06
EP3473629A4 (en) 2020-01-22
EP3473629A1 (en) 2019-04-24
MX2018016267A (es) 2019-05-20
JPWO2017221869A1 (ja) 2018-07-05
KR20190017991A (ko) 2019-02-20
JP6959077B2 (ja) 2021-11-02
US20210230187A1 (en) 2021-07-29
JP6212678B1 (ja) 2017-10-11

Similar Documents

Publication Publication Date Title
AR108812A1 (es) Proceso para preparar un derivado de piridona policíclica sustituida y cristal del mismo
AR107616A1 (es) Compuestos de 6,7-dihidro-5h-benzo[7]anuleno sustituidos, procesos para su preparación y usos terapéuticos de los mismos
AR109788A1 (es) Compuestos de benzo[b]tiofeno como agonistas de sting
PE20190326A1 (es) Isoquinolin-3-il-carboxamidas y preparacion y uso de las mismas
AR112834A1 (es) Derivados de rapamicina
AR111689A1 (es) Tienopiridinas y benzotiofenos útiles como inhibidores de irak4
AR103222A1 (es) Procedimiento para la preparación de análogos de 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidina
AR106472A1 (es) Inhibidores de acc y usos de los mismos
AR094668A1 (es) Amidas como moduladores de canales de sodio
AR103251A1 (es) Compuestos policíclicos de carbamoilpiridona y su uso farmacéutico
AR107032A1 (es) Inhibidores bicíclicos de pad4
AR097082A1 (es) Compuestos terapéuticamente activos y sus métodos de uso
AR096238A1 (es) Proceso para preparar derivados de 3-((2s,5s)-4-metilen-5-(3-oxopropil)tetrahidrofuran-2-il)propanol e intermediarios útiles para el mismo
BR112016019462B8 (pt) Compostos heterocïclicos tricïclicos como inibidores de fosfoinosotida 3-cinase
AR104880A1 (es) MODULADORES DE ROR GAMMA (RORg)
AR087915A1 (es) N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la bace1
AR098522A1 (es) Compuesto de triazolo-piridina
AR109735A1 (es) Método para la síntesis de derivado de 3-fenil-2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno e isómero óptico del mismo
AR097435A1 (es) 6-alquinilpiridinas
DOP2017000034A (es) Compuestos de imidazopiridazina
AR099914A1 (es) Derivados de indol y de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
AR103266A1 (es) Compuestos cíclicos sustituidos con un sistema de anillos condensado para combatir plagas de invertebrados
AR098818A1 (es) Derivados de oxindol, preparación de los mismos y uso terapéutico de los mismos
AR109711A1 (es) Inhibidores de fosfatidilinositol 3-quinasa
AR102258A1 (es) Compuestos de quinolina y quinazolina